RecruitingPhase 1NCT05111561
Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer
Sponsor: National Cancer Institute (NCI)
Galveston, TX · Houston, TX · +2 more sites